Clinical Trials Browser

Phase 2 × Terminated × becatecarin × Clear all

NCT00084487 2014-05-23

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Phase 2 Terminated

21 enrolled 12 charts

Small Cell Lung Carcinoma

NCT00006262 2012-06-11

Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

Phase 2 Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00005997 2010-06-11

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Phase 2 Terminated

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms